AzTrials
AzTrials

LaryngoscopyNCT07510542

Comparison of Stress Response Evoked by Conventional Versus Videolaryngoscope

A study testing Endotracheal Intubation through a Video Laryngoscope (VL) and Endotracheal Intubation through a Direct Laryngoscope (DL) in people with Laryngoscopy and Stress Response, run by Sindh Institute of Urology and Transplantation at 1 site in Pakistan.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Impact of using video laryngoscopy versus direct laryngoscopy technique in terms of improved hemodynamics post intubation and time taken for intubation. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Laryngoscopy, Stress Response, Duration
What is being tested?
Endotracheal Intubation through a Video Laryngoscope (VL) and Endotracheal Intubation through a Direct Laryngoscope (DL)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
124 participants
Where
1 sitePakistan
Study dates
5 Mar 2026to 5 Sep 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • ASA I \& II
  • Age 18-60 years.
  • Preoperatively nonhypertensive and hemodynamically stable patients
  • Patients scheduled for elective procedures not involving airway surgeries
  • Patients with informed consent
  • Mallampati score I and II
  • Interincisor gap > 3 cms
  • BMI less than 30 kg/m²

Who cannot join

  • Patient refusal
  • ASA III, IV \& V
  • Hemodynamically unstable patients
  • Patients with Hypertension and Ischemic Heart Disease (whether controlled or uncontrolled)
  • Airway abnormalities, including congenital airway malformations \& maxillofacial abnormalities
  • Head, neck or any facial traumas or history of prior head, neck or airway surgeries
  • Emergency procedures
  • Pregnancy

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Pakistan1 site, 1 recruiting
  • Sindh Institute of Urology and Transplantation

    Karachi, Sindh, 74200

    Syed M Abbas, FCPS, +923331318838, smabbas69@hotmail.com

    Recruiting

Other trials in Pakistan

About this study

Official title: Comparison of the Efficacy of Non-channelled Video Laryngoscopy Versus Direct Laryngoscopy in Terms of Stress Response and Intubation Time: a Single-blinded Randomized Controlled Trial

Impact of using video laryngoscopy versus direct laryngoscopy technique in terms of improved hemodynamics post intubation and time taken for intubation.

Read the detailed description

The research will be conducted as a single-blind study involving patients undergoing elective surgical processes that necessitate endotracheal intubation. Informed consent will be obtained from all patients. Participants will be randomly assigned through a computer-generated sequence number to either the DL (direct laryngoscopy) group or the VL (video laryngoscopy) group. Monitoring will include vital signs and measurements such as non-invasive blood pressure (NIBP), electrocardiography (ECG), and pulse oximetry (SpO2). Prior to the induction of anesthesia, each patient will undergo assessments including oxygen saturation, blood pressure, echocardiography, systolic, diastolic, and mean blood pressure, heart rate, and oxygen saturation. In addition to the stated observations, the same assessments will be done after one minute of induction, after three minutes of bag-mask ventilation, and one, three, and five minutes after intubation. The time taken to perform endotracheal intubation will also be noted for both direct laryngoscopy and video laryngoscopy. All subjects will be premedicated with Inj. midazolam 0.03 mg/kg. For all patients, the same general anesthesia protocol will be applied, with patients preoxygenated with 100% oxygen for three minutes prior to induction, which will be done with Inj. Nalbuphine 0.15 mg/kg and Inj. propofol 2 mg/kg I.V. After evaluating bag-mask ventilation, Inj. Atracurium at 0.6 mg/kg I.V. will be administered, and isoflurane at 1.2% (1 MAC) will be initiated. After three minutes of bag-mask ventilation, intubation will be performed using either direct laryngoscopy or a non-channelled video laryngoscope, and the time taken for laryngoscopy and intubation will be recorded. Based on the groups, one of the two methods will be utilized to insert the appropriate endotracheal tube. In Group A, endotracheal intubation will be conducted using an indirect non-channelled VL. In Group B, endotracheal intubation will be performed using DL. The placement of the tube will be verified through capnography and chest auscultation before it is secured in position.

Group A The intubation process will utilize the Besdata (BD-M7) Portable VL, which is an indirect laryngoscope without a channel. The investigator will use a curved rigid stylet that is pre-shaped to match the laryngoscope blade, allowing for intubation with either a size 3 or 4 blade. In this research, the time taken for intubation will be recorded using an external timer. This involves measuring the interval from when the blade is inserted into the patient's mouth to the detection of the first capnography wave, while simultaneously using the timer to monitor vital parameters.

Group B Endotracheal tube (ETT) insertion via DL with a blade size of either 3 or 4 in the patients; the same external timer will be used as for group A.

Laryngoscopy in both groups will be conducted by an anesthetist with a minimum of five years of experience in anesthesia practice, ensuring the provision of high-quality care across both groups.

Data Analysis: The data collected will be analyzed via the SPSS software package v.26.0. Numerical variables will be presented as means (standard deviations) for normally distributed variables and as medians (IQRs) for non-normally distributed variables. For categorical variables (as frequencies), and group comparisons between numerical and categorical variables will be performed via the unpaired t-tests and the chi-square tests, respectively.

A p-value < 0.05 will be considered statistically significant.

Being tested
Endotracheal Intubation through a Video Laryngoscope (VL), Endotracheal Intubation through a Direct Laryngoscope (DL)
Keywords
Laryngoscopy, Stress response, Video laryngoscope
Medical subject headings
Fractures, Stress

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Endotracheal Intubation through a Video Laryngoscope (VL)Device

    In this group, endotracheal intubation will be done through a video laryngoscope

  • Endotracheal Intubation through a Direct Laryngoscope (DL)Device

    In this group, endotracheal intubation will be done through a direct laryngoscope

Study groups in NCT07510542
Study groupRoleWhat they receive
Video Laryngoscope (VL)ExperimentalThe intubation process will utilize the Besdata (BD-M7) Portable Video Laryngoscope (VL), which is an indirect laryngoscope without a channel. We use a curved rigid stylet that is pre-shaped to match the laryngoscope blade, allowing for intubation with either a size 3 or 4 blade. In this research, the time taken for intubation will be recorded using an external timer. This involves measuring the interval from when the blade is inserted into the patient's mouth to the detection of the first capnography wave, while simultaneously using the timer to monitor vital parameters.
Receives: Device: Endotracheal Intubation through a Video Laryngoscope (VL)
Direct Laryngoscope (DL)Active comparatorEndotracheal tube (ETT) insertion via Direct Laryngoscope (DL) with a blade size of either 3 or 4 in the patients; the same external timer will be used as for group VL. Laryngoscopy in both groups will be conducted by an anaesthetist with a minimum of five years of experience in anaesthesia practice, ensuring the provision of high-quality care across both groups.
Receives: Device: Endotracheal Intubation through a Direct Laryngoscope (DL)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Heart rate

    Heart rate will be monitored through a 3-lead ECG monitor

    Measured: Perioperative

  2. Systolic Blood Pressure

    Systolic Blood Pressure will be monitored via a non-invasive blood pressure monitor with an appropriate BP cuff attached to any arm of the patient.

    Measured: Perioperative

  3. Diastolic Blood Pressure

    Diastolic blood pressure will be monitored via a non-invasive blood pressure monitor with an appropriate BP cuff attached to any arm of the patient.

    Measured: Perioperative

  4. Mean Blood Pressure

    Mean blood pressure will be monitored via a non-invasive blood pressure monitor with an appropriate BP cuff attached to any arm of the patient.

    Measured: Perioperative

Secondary outcomes (1)
  1. Duration of Laryngoscopy

    The time taken to perform endotracheal intubation will also be noted for both direct laryngoscopy and video laryngoscopy. This involves measuring the interval from when the laryngoscope blade is inserted into the patient's mouth to the detection of the first capnography wave, while simultaneously using the timer to monitor vital parameters.

    Measured: Perioperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Apr 2026
  2. Study start5 Mar 2026
  3. Primary completion5 Sep 2026 (estimated)
  4. Study completion5 Sep 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
124 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07510542
Sponsor's protocol ID
SIUT-ERC-2026/A-629
Other IDs
SIUT-ERC-2026/A-629
Status last verified
Apr 2026
First submitted
17 Mar 2026
Last updated
3 Apr 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Endotracheal Intubation through a Video Laryngoscope (VL) and Endotracheal Intubation through a Direct Laryngoscope (DL) in people with Laryngoscopy and Stress Response, run by Sindh Institute of Urology and Transplantation at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 8 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 3 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Syed M Abbas, FCPS (02199215718 ext. 2193, smabbas1969@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Heart rate (time frame: Perioperative). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Apr 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in